Global Markets for Rapid Medical Diagnostic Kits

Published - Jun 2013| Analyst - Peggy Lehr| Code - HLC007H
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

The global market for rapid medical diagnostic kits (MDK) was $16.5 billion in 2011 and nearly $18.4 billion in 2012. This market is expected to reach $24.2 billion in 2017, at an estimated compound annual growth rate (CAGR) of 5.7% from 2012 to 2017.

Report Includes

  • An overview of the market for rapid medical diagnostic kits, with an intensive examination of the in vitro diagnostic kit segment of the medical device market.
  • Analyses of market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Discussion of changes that have occurred over the last five years as the result of technological advances and regulatory implementations, and the impact those changes will have on the overall market and key market segments.
  • Examination of the effect on the market of inexpensive, automated testing devices, known as point-of-care (POC) instruments, which have replaced MDKs in smaller laboratories and physicians’ offices.
  • Emerging marketing practices, such as strategic alliances and acquisitions.
  • Coverage of the effect of external market forces, such as insurance and increased incidence of disease.


The report concentrates on rapid MDK and their position in the overall MDK market. The report specifically excludes tests that involve automated testing or tests that require processing devices and semiautomated batch testing devices.

The rapid MDK market encapsulates current and potential products, related technologies, components and component suppliers, end markets, governmental and regulatory agencies, major companies competing in this market, relative market shares and the impact of the worldwide market status.

This study defines the MDK market and provides detailed information on the following:

  • Products that comprise the rapid MDK industry.
  • Emerging and current MDK technologies.
  • Analysis of these technologies and the effect on future market development.
  • Market structure and current market size, with forecasts by type of product and market region from 2012 to 2017.
  • The effect of external market forces, such as insurance, regulatory and economic issues and increased incidence of disease.


Peggy S. Lehr is the BCC research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and a MS in Communication from the University of Denver. Ms. Lehr has been involved with the medical/nursing industry for more than 20 years, and she has worked within the publishing industry for both for-profit and not-for-profit organizations. Recent reports for BCC include seven healthcare reports and her latest report, PHM061B, on the global infectious disease market.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Published - May-2008| Analyst - Vicki McConnell| Code - HLC007G

Report Highlights

  • The U.S. market for medical diagnostic kits (MDKs) increased from $11.2 billion in 2007 to an estimated $12.2 billion by the end of 2008. It should reach $18.5 billion in 2013, a compound annual growth rate (CAGR) of 8.7%.
  • MDKs accounted for approximately 23% of all clinical diagnostic testing in the U.S. in 2007. With the increased market share by instrumentation suites, this share is expected to decline to 20% by 2013.
  • Point-of-care (POC) instruments have affected the use of MDKs because of the benefits they offer including improved cost efficiencies and rapid results.
Published - Apr-2002| Analyst - Barbara Breindel| Code - HLC007F

Report Highlights

  • In 2001, sales at the U.S. manufacturers level exceeded $3.8 billion. By 2006, the market is anticipated to grow at an average annual rate (AAGR) of 6.2% to yield sales of more than $5.1 billion.
  • MDKs accounted for 34.6% of all diagnostic testing in the U.S. in 2001 and by 2006, market share will drop to 30.8%.
  • Point-of-care (POC) instruments have impacted the use of MDKs because of the benefits they offer for improving patient care.
  • The veterinary MDK segment has not developed as previously expected. Sales to this segment only reached an estimated $296 million in 2001 and the AAGR is projected to be only 2% through 2006.
  • Scientific advances resulting from the study of the human genome have fueled an increase in the use of MDKs in the research segment. Average annual growth is expected to be 10.5% through 2006.


Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report